Industry News
Researchers discover mechanism that limits scar formation
Senescent cells in wounds appear to have the biological effect of inhibiting the formation of excess scar tissue.
[ + ]Healthscope to provide OvPlex ovarian cancer test in Australia
Melbourne biotech HealthLinx announced today that it will resume distribution its OvPlex ovarian cancer biomarker test through Healthscope’s national network of collection centres after the healthcare provider’s acquisition of ARL Pathology last year. [ + ]
The science behind the 2010 World Cup soccer ball
University of Adelaide physicists have tested the new soccer ball created for the 2010 World Cup and can explain why it will play 'harder and faster' and bend more unpredictably than its predecessor.
[ + ]New Australian cancer drug advances towards human trials
Queensland biotech QBiotics announced at the weekend it is seeking to raise $10 million to fund Phase 1 human trials of its EBC-46 cancer drug. [ + ]
Science-oriented students to compete for Olympic Gold
Sixteen Australian senior school students will take part in the 2010 International Science Olympiads in biology, physics and chemistry.
[ + ]Rapid, effective system for monitoring mosquito-borne disease
A University of Western Australia researcher has exploited mosquitoes' love of honey to develop a rapid and effective method for monitoring mosquito-borne disease.
[ + ]Market report: Local shares rise on U.S optimism about China and Europe
The Australian share market rose today following a strong lead from U.S markets overnight after China reported robust export data and European markets reversed some of their recent losses. [ + ]
Vaisala acquires Veriteq
Vaisala has strengthened its position in the life science market through the strategic acquisition of Veriteq Instruments.
[ + ]Monash PhD student leads major insulin breakthrough
A PhD student from Monash University has succeeded in tweaking the chemical structure of insulin leading potentially to the development of medications that are stable at room temperature. [ + ]
Queensland’s best researchers honoured in QHMR Awards
The Queensland Health and Medical Research Awards held in Brisbane last Friday honoured a number of outstanding individuals for their work in areas including pain treatment, immunology, lymphoma and post transplant disorders. [ + ]
British biotech boasts antibiotic breakthrough
A British biotech company is preparing for phase II trials of a new antibiotic being viewed as a major leap forward in the fight against drug -resistant strains of bacteria. [ + ]
BRCA1 gene patent challenged in Australian court
A consortium has launched legal action against four biotechnology companies, including Genetic Technologies (GTG), challenging the validity of patents concerning genetic material. [ + ]
Government announces $440,000 to bolster overseas collaborations
The federal government has announced new funding of $440,000 to support 69 research collaborations between Australian and overseas groups, as part of the International Science Linkages – Science Academies Program. [ + ]
Dynamin linked to Alzheimer's and bipolar disorder
Dynamin is well known for its role in controlling endocytosis, particularly in synaptic vesicles in nerve cells and for its pivotal role in the brain. [ + ]
